CAM
VIVO

Capstone Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Capstone Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,242
Closed -$210K – 1616
2017
Q1 		$210K Sell
15,242
-235,554
-94% -$3.29M 0.01% 1511
2016
Q4 		$4.44M Buy
250,796
+9,518
+4% +$167K 0.13% 192
2016
Q3 		$4.65M Buy
241,278
+5,839
+2% +$114K 0.13% 169
2016
Q2 		$4.59M Buy
235,439
+5,473
+2% +$107K 0.14% 167
2016
Q1 		$4.74M Buy
229,966
+216,115
+1,560% +$4.26M 0.14% 182
2015
Q4 		$284K Sell
13,851
-110
-0.8% -$2.11K 0.01% 1313
2015
Q3 		$239K Buy
13,961
+1,340
+11% +$24.5K 0.01% 1376
2015
Q2 		$235K Sell
12,621
-5,245
-29% -$97.3K 0.01% 1436
2015
Q1 		$341K Buy
17,866
+340
+2% +$6.29K 0.01% 1319
2014
Q4 		$288K Sell
17,526
-2,476
-12% -$42.5K 0.01% 1393
2014
Q3 		$354K Sell
20,002
-4,004
-17% -$78.7K 0.01% 1246
2014
Q2 		$495K Buy
24,006
+1,886
+9% +$38.8K 0.02% 1077
2014
Q1 		$482K Sell
22,120
-150,856
-87% -$3.46M 0.01% 1100
2013
Q4 		$4.59M Buy
172,976
+323
+0.2% +$7.94K 0.13% 180
2013
Q3 		$4.08M Buy
172,653
+2,666
+2% +$62.3K 0.1% 228
2013
Q2 		$3.65M Buy
+169,987
New +$3.67M 0.1% 227

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capstone Asset Management's VIVO Position: Q2 2017 in Review

Capstone Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2017, closing a stake of 15,242 shares — an estimated $210K sold.

Capstone Asset Management first reported a position in VIVO in Q2 2013 and held it in 16 quarters. The position peaked at $4.74M in Q1 2016. 170 funds tracked by Wall St. Rank hold VIVO as of Q2 2017.

  • Capstone Asset Management reported no remaining Meridian Bioscience Inc position as of Q2 2017 after selling out during the quarter.
  • Capstone Asset Management sold 15,242 Meridian Bioscience Inc shares in Q2 2017, an estimated $210K.
  • Capstone Asset Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 16 quarters.
  • Capstone Asset Management's Meridian Bioscience Inc position peaked at $4.74M in Q1 2016.
  • 170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.